Close

Catyalyst Pharmaceutical Partners (CPRX) Cuts Q2 Loss by 1c

August 16, 2011 8:05 AM EDT
Catyalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) reported Q2 EPS of ($0.06), versus ($0.07) reported last year.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings